Skip to content

Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial.

Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial. - Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011753
Enrollment
80
Registered
2013-09-13
Start date
2013-08-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Duration: 4 weeks Test material: Eurycoma Longifolia root extract.......200 mg/day Once/day Duration: 4 weeks Test material: Rice powder.......200mg Once/day

Sponsors

ORTHOMEDICO, Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara clinic. Institute for Health &amp
Collaborator
Life Science.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a) Healthy adults, who feel fatigue daily b) Persons whose ages are between 40 and 59 years old c) Low immunity score (SIV less than 23) on visit 1's examination

Exclusion criteria

Exclusion criteria: a) Persons who have previous medical history of heart failure and cardiacinfarction b) Patients being treated for arterial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, dyslipidemia, hypertension, and other chronic disease c) Persons who takes medicines, herbal medicines, and dietary supplements within 30 days d) Persons who has allergy e) Pregnant women, lactating women, or women who want to get pregnant during the trial period f) Pollinosis patients g) Smokers h) Persons who enrolled in the other clinical trials within last 3 months before the agreement for the participation to the trial i) Persons who investigator judge not suitable to participate in the trial

Design outcomes

Primary

MeasureTime frame
Scoring of Immunological Vigor Immunological Parameters

Secondary

MeasureTime frame
Total testosterone, Free testosterone Questionnaires (POMS, Likert) Blood test Urinary test Physical examinations Marketing questionnaire

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO, Inc. R&D department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026